Connect-One: Early Feasibility Study of Connexus® Brain-Computer Interface (BCI)
Recruiting
N/A
Interventional Study
Amyotrophic Lateral Sclerosis
Neuromuscular Disease
Stroke
Tetraplegia/Tetraparesis
Cervical Spinal Cord Injury
Dysarthria
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 22 – 75
- Sex
- Any
- Study type
- Interventional
- Purpose
- Other
- Participants needed
- 2 (estimated)
- Sponsor
- Paradromics · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The Connect-One Study is an early feasibility study to obtain preliminary device safety information for the Connexus Brain-Computer Interface (BCI). The Connexus BCI is intended to be used as: (1) an assistive communication device to decode imagined language correlates and speech for patients with impaired communication as a result of severe loss of voluntary motor control; and (2) to provide cont…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Clinical diagnosis of a progressive neuromuscular disease or a neurological injury.
* Clinical diagnosis of anarthria or severe dysarthria.
* Wheelchair dependent with severely impaired upper limb function.
* Has a reliable method of communication and the ability to read and u…
Contacts